Clinical trial
An Open-label Pilot Study of Dose Escalation of PEGASYS on Virological Response in Patients With Chronic Hepatitis C Viral Infection Showing an Early Non-response to a Standard Course of PEGASYS Plus Ribavirin
NCT02791256 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Pilot Study of Dose Escalation of PEGASYS on Virological Response in Patients With Chronic Hepatitis C Viral Infection Showing an Early Non-response to a Standard Course of PEGASYS Plus Ribavirin
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2005
- Completion date
- June 30, 2008
- Enrollment
- 23 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.